Scott Tarriff - 28 Feb 2022 Form 4 Insider Report for EAGLE PHARMACEUTICALS, INC. (EGRX)

Role: CEO, Director, 10%+ Owner
Signature: /s/ Scott Tarriff
Issuer symbol: EGRX
Transactions as of: 28 Feb 2022
Net transactions value: $0
Form type: 4
Filing time: 02 Mar 2022, 17:02:00 UTC
Next filing: 09 Jan 2023
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	EGRX	Common Stock	Award	$0	+34,800	+2.3%	$0.000000	1,579,706	28 Feb 2022	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Each restricted stock unit ("RSU") represents the contingent right to receive one share of the Issuer's common stock upon vesting of the unit. The shares issuable in respect of such RSUs shall vest with respect to 25% of the shares of common stock on each of the one, two, three and four-year anniversaries of February 28, 2022, subject to the Reporting Person's continuous service with the Issuer as of the applicable vesting date.

Content

Each restricted stock unit ("RSU") represents the contingent right to receive one share of the Issuer's common stock upon vesting of the unit. The shares issuable in respect of such RSUs shall vest with respect to 25% of the shares of common stock on each of the one, two, three and four-year anniversaries of February 28, 2022, subject to the Reporting Person's continuous service with the Issuer as of the applicable vesting date.